Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Understanding TR indices helps investors gauge real performance by including income. This primer covers definitions, uses, and limitations for smarter choices.
27,608 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Want dividend income you can rely on for decades? Learn how to pick the best dividend stocks hold through downturns, ...
Bitcoin breached the $80,000 mark, but market watchers say the rally is not backed by solid demand. The bitcoin marke...
As AI moves from training models to everyday tools, two growth stocks smarter plays stand out as durable winners. Dis...
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...
Investors face a clear choice between NOV and SLB N.V. in a shifting energy landscape. This guide breaks down busines...
As March kicks off, many investors look for a starting point in energy. Here's first energy stock could fit a growth-...
Two popular energy plays diverge in method and risk: broad oil and gas exposure versus infrastructure income. Learn h...
A director sold 33,000 Clear Secure shares worth about $1.5 million, sparking questions about the stock's outlook. Th...
Pfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
When a top executive sells a large block of shares, investors want clarity. This guide breaks down what RingCentral's...
Cognition CEO Scott Wu says token-based leadership metrics have inflated AI spending. The firm urges measuring employ...